Monitoring for Extra-Intestinal Cancers in IBD
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11894-015-0467-8.pdf
Reference41 articles.
1. Magro F, Peyrin-Biroulet L, Sokol H, et al. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (III). J Crohns Colitis. 2014;8(1):31–44. Review published by the European Crohn’s and Colitis Organization Pathogenesis scientific workshop that reviews the epidemiology, carcinogenesis and screening/prevention/surveillance for lymphoproliferative disorders, uterine cervix abnormalities and skin cancers in IBD.
2. Algaba A, Guerra I, Castano A, et al. Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease. World J Gastroenterol. 2013;19(48):9359–65.
3. Harwood CA, Attard NR, O’Donovan P, et al. PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients. Br J Cancer. 2008;99(8):1276–84.
4. Munz C, Moormann A. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol. 2008;18(6):381–7.
5. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6(10):715–27.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review;Cancers;2023-07-27
2. Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2023-05-23
3. Myelolipoma After Infliximab Treatment for Crohn's Disease;ACG Case Reports Journal;2022-07
4. Prevalence of abnormal Pap smear results in inflammatory bowel disease: a prospective study;Journal of Cancer Research and Clinical Oncology;2022-01-03
5. The Incidence Rate and Risk Factors of Malignancy in Elderly-Onset Inflammatory Bowel Disease: A Chinese Cohort Study From 1998 to 2020;Frontiers in Oncology;2021-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3